ABSTRACT

Objective: To determine the efficacy and acceptability of levonorgestrel-releasing intrauterine device (LNG-IUD) in females with heavy menstrual bleeding (HMB).
Study Design: A Quasi-experimental study design.
Place and Duration of Study: The Study was conducted at the Obstetrics and Gynecology Department of Pak Emirates Military Hospital (PEMH) Rawalpindi, Pakistan for a duration of 6 months from November 2022 to April 2023.
Methods: A total of 96 patients accomplishing the selection criteria were enrolled after taking written informed consent after the screening, LNG-IUD was inserted in all participants and patients were followed up till the 6^th menstrual cycle and outcomes (like having less bleeding or amenorrhea, improvement in hemoglobin, improvement in doing daily tasks, etc.) were assessed.
Results: The mean age of the females was 38.08 5.83 years. Efficacy of treatment was seen in 64 (66.7%) females, and acceptability was seen in 61 (63.5%) females. In terms of side effects, spotting occurred in 17 (17.7%) patients, amenorrhea in 3 (3.1%) patients, oligomenorrhea in 4 (4.2%) patients, weight gain in 6 (6.3%) patients, breast heaviness in 3 (3.1%) patients, 3 (3.1%) females had mood fluctuations and 2 (2.1%) had depression.
Conclusion: For treating females with HMB, LNG-IUD was efficacious in 66.7% of females and acceptable in 63.5% of females.

Keywords: Heavy Menstrual Bleeding, Intrauterine Device. Levonorgestrel.

How to cite this: Kousar R, Khan FS, Yazdani T, Kousar R, Mehmood F, Munir M. Study of Efficacy and Acceptability of Levonorgestrel-Releasing Intrauterine Device in Heavy Menstrual Bleeding Patients. Life and Science. 2024; 5(3): 329-335. doi: http://doi.org/10.37185/LnS.1.1.409